Mise à disposition du Rapport Financier annuel 2017. pdfLire

Sensorion and Uconn Health Announce Identification of First Potential Biomarker for Noise-Induced Hearing Loss. pdfRead

Sensorion’s SENS-401 Reduces Hearing Loss in Preclinical Study When Oral Administration Initiated Up to Four Days after Acoustic Trauma. pdfRead

Sensorion confirme son éligibilité au dispositif PEA-PME. pdfLire

Sensorion reports full year 2017 results. pdfRead


2018 08 Pipeline


Patient center

Corporate presentation

Next events